Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

The Effect of Probiotic and Synbiotic Consumption on the Most Prevalent Chemotherapy-related Complications: A Systematic Review of Current Literature

Author(s): Arman Arab, Elham Karimi, Mohammad Bagherniya*, Thozhukat Sathyapalan and Amirhossein Sahebkar*

Volume 29, Issue 33, 2022

Published on: 30 June, 2022

Page: [5462 - 5473] Pages: 12

DOI: 10.2174/0929867329666220415114343

Price: $65

Abstract

Background: To date, many investigations have employed pro-/synbiotic to examine their effects on chemotherapy-related side effects; nevertheless, their findings are inconclusive. To address this issue, we carried out a systematic review to explore the effect of pro- /synbiotic consumption on chemotherapy-related side effects, including nausea, vomiting, mucositis, diarrhea, and constipation in adults using randomized controlled trials (RCTs).

Methods: The electronic databases, including PubMed, Scopus, and ISI Web of Sciences, were searched systematically from the earliest available date to March 2021 to identify eligible studies. The quality of the enrolled studies was assessed based on the Cochrane Collaboration Risk of Bias tool.

Results: A total of 10 studies involving 788 individuals were included in the current systematic review, with the sample size ranging from 25 to 200 and the mean age ranging from 51.04 to 66.91 years. The findings of this study imply that probiotic consumption may be more effective in terms of mucositis compared to other complications.

Conclusion: Further good-quality RCTs with better methodology are required to determine whether and how pro-/synbiotics can prevent or treat chemotherapy-induced side effects. The current systematic review findings may help investigators of future studies in selecting the study population and probiotic strains.

Keywords: Cancer, probiotic, synbiotic, chemotherapy complications, RCTs, mucositis.

« Previous
[1]
Aslam, M.S.; Naveed, S.; Ahmed, A.; Abbas, Z.; Gull, I.; Athar, M.A. Side effects of chemotherapy in cancer patients and evaluation of patients opinion about starvation based differential chemotherapy. J. Cancer Ther. 2014, 2014.
[http://dx.doi.org/10.4236/jct.2014.58089]
[2]
Pearce, A.; Haas, M.; Viney, R.; Pearson, S.-A.; Haywood, P.; Brown, C. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS One,, 2017, 12(10) e0184360-e
[3]
Kuo, S.H.; Lien, H.C.; You, S.L.; Lu, Y.S.; Lin, C.H.; Chen, T.Z.; Huang, C.S. Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients. Breast (Edinburgh, Scotland), 2008, 17(6), 646-653.
[http://dx.doi.org/10.1016/j.breast.2008.05.006] [PMID: 18595699]
[4]
Jiang, C.; Wang, H.; Xia, C.; Dong, Q.; Chen, E.; Qiu, Y.; Su, Y.; Xie, H.; Zeng, L.; Kuang, J.; Ao, F.; Gong, X.; Li, J.; Chen, T. A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. Cancer, 2019, 125(7), 1081-1090.
[http://dx.doi.org/10.1002/cncr.31907] [PMID: 30521105]
[5]
Roy, S.; Trinchieri, G. Microbiota: A key orchestrator of cancer therapy. Nat. Rev. Cancer, 2017, 17(5), 271-285.
[http://dx.doi.org/10.1038/nrc.2017.13] [PMID: 28303904]
[6]
Arabi, S.M.; Bahrami, L.S.; Rahnama, I.; Sahebkar, A. Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res., 2022, 176106061
[http://dx.doi.org/10.1016/j.phrs.2022.106061] [PMID: 34999222]
[7]
Davoodvandi, A.; Fallahi, F.; Tamtaji, O.R.; Tajiknia, V.; Banikazemi, Z.; Fathizadeh, H.; Abbasi-Kolli, M.; Aschner, M.; Ghandali, M.; Sahebkar, A.; Taghizadeh, M.; Mirzaei, H. An update on the effects of probiotics on gastrointestinal cancers. Front. Pharmacol., 2021, 12680400
[http://dx.doi.org/10.3389/fphar.2021.680400] [PMID: 34992527]
[8]
Davoodvandi, A.; Marzban, H.; Goleij, P.; Sahebkar, A.; Morshedi, K.; Rezaei, S.; Mahjoubin-Tehran, M.; Tarrahimofrad, H.; Hamblin, M.R.; Mirzaei, H. Effects of therapeutic probiotics on modulation of microRNAs. Cell Commun. Signal., 2021, 19(1), 4.
[http://dx.doi.org/10.1186/s12964-020-00668-w] [PMID: 33430873]
[9]
Esmaeili, S.A.; Mahmoudi, M.; Momtazi, A.A.; Sahebkar, A.; Doulabi, H.; Rastin, M. Tolerogenic probiotics: Potential immunoregulators in Systemic Lupus Erythematosus. J. Cell. Physiol., 2017, 232(8), 1994-2007.
[http://dx.doi.org/10.1002/jcp.25748] [PMID: 27996081]
[10]
Hajavi, J.; Esmaeili, S.A.; Varasteh, A.R.; Vazini, H.; Atabati, H.; Mardani, F.; Momtazi-Borojeni, A.A.; Hashemi, M.; Sankian, M.; Sahebkar, A. The immunomodulatory role of probiotics in allergy therapy. J. Cell. Physiol., 2019, 234(3), 2386-2398.
[http://dx.doi.org/10.1002/jcp.27263] [PMID: 30192002]
[11]
Morshedi, M.; Hashemi, R.; Moazzen, S.; Sahebkar, A.; Hosseinifard, E.S. Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: A systematic review. J. Neuroinflammation, 2019, 16(1), 231.
[http://dx.doi.org/10.1186/s12974-019-1611-4] [PMID: 31752913]
[12]
Panahi, Y.; Ghanei, M.; Vahedi, E.; Mousavi, S.H.; Imani, S.; Sahebkar, A. Efficacy of probiotic supplementation on quality of life and pulmonary symptoms due to sulfur mustard exposure: A randomized double-blind placebo-controlled trial. Drug Chem. Toxicol., 2017, 40(1), 24-29.
[http://dx.doi.org/10.3109/01480545.2016.1166250] [PMID: 27079636]
[13]
Farshi Radvar, F.; Mohammad-Zadeh, M.; Mahdavi, R.; Andersen, V.; Nasirimotlagh, B.; Faramarzi, E. Effect of synbiotic supplementation on matrix metalloproteinase enzymes, quality of life and dietary intake and weight changes in rectal cancer patients undergoing neoadjuvant chemoradiotherapy. Med. J. Nutrition Metab., 2020, 13(3), 225-235.
[http://dx.doi.org/10.3233/MNM-200413]
[14]
Limaye, S.A.; Haddad, R.I.; Cilli, F.; Sonis, S.T.; Colevas, A.D.; Brennan, M.T.; Hu, K.S.; Murphy, B.A. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer, 2013, 119(24), 4268-4276.
[http://dx.doi.org/10.1002/cncr.28365] [PMID: 24114811]
[15]
Mego, M.; Chovanec, J.; Vochyanova-Andrezalova, I.; Konkolovsky, P.; Mikulova, M.; Reckova, M.; Miskovska, V.; Bystricky, B.; Beniak, J.; Medvecova, L.; Lagin, A.; Svetlovska, D.; Spanik, S.; Zajac, V.; Mardiak, J.; Drgona, L. Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study. Complement. Ther. Med., 2015, 23(3), 356-362.
[http://dx.doi.org/10.1016/j.ctim.2015.03.008] [PMID: 26051570]
[16]
Topuz, E.; Derin, D.; Can, G.; Kürklü, E.; Çinar, S.; Aykan, F.; Cevikbaş, A.; Dişçi, R.; Durna, Z.; Sakar, B.; Saglam, S.; Tanyeri, H.; Deniz, G.; Gürer, U.; Taş, F.; Guney, N.; Aydiner, A. Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer. Invest. New Drugs, 2008, 26(6), 567-572.
[http://dx.doi.org/10.1007/s10637-008-9171-y] [PMID: 18762864]
[17]
Zaharuddin, L.; Mokhtar, N.M.; Muhammad Nawawi, K.N.; Raja Ali, R.A. A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer. BMC Gastroenterol., 2019, 19(1), 131.
[http://dx.doi.org/10.1186/s12876-019-1047-4] [PMID: 31340751]
[18]
Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int. J. Surg., 2010, 8(5), 336-341.
[http://dx.doi.org/10.1016/j.ijsu.2010.02.007] [PMID: 20171303]
[19]
Higgins, J.P.; Altman, D.G.; Gøtzsche, P.C.; Jüni, P.; Moher, D.; Oxman, A.D.; Savovic, J.; Schulz, K.F.; Weeks, L.; Sterne, J.A. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 2011, 343, d5928.
[http://dx.doi.org/10.1136/bmj.d5928] [PMID: 22008217]
[20]
Liu, J.; Huang, X.E. Efficacy of bifidobacterium tetragenous viable bacteria tablets for cancer patients with functional constipation. Asian Pac. J. Cancer Prev., 2014, 15(23), 10241-10244.
[http://dx.doi.org/10.7314/APJCP.2014.15.23.10241] [PMID: 25556454]
[21]
Österlund, P.; Ruotsalainen, T.; Korpela, R.; Saxelin, M.; Ollus, A.; Valta, P.; Kouri, M.; Elomaa, I.; Joensuu, H. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: A randomised study. Br. J. Cancer, 2007, 97(8), 1028-1034.
[http://dx.doi.org/10.1038/sj.bjc.6603990] [PMID: 17895895]
[22]
Sharma, A.; Rath, G.K.; Chaudhary, S.P.; Thakar, A.; Mohanti, B.K.; Bahadur, S. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study. Eur. J. Cancer, 2012, 48(6), 875-881.
[http://dx.doi.org/10.1016/j.ejca.2011.06.010] [PMID: 21741230]
[23]
Tian, Y.; Li, M.; Song, W.; Jiang, R.; Li, Y.Q. Effects of probiotics on chemotherapy in patients with lung cancer. Oncol. Lett., 2019, 17(3), 2836-2848.
[http://dx.doi.org/10.3892/ol.2019.9906] [PMID: 30854059]
[24]
Redman, M.G.; Ward, E.J.; Phillips, R.S. The efficacy and safety of probiotics in people with cancer: A systematic review. Ann. Oncol., 2014, 25(10), 1919-1929.
[http://dx.doi.org/10.1093/annonc/mdu106] [PMID: 24618152]
[25]
Thomsen, M.; Clarke, S.; Vitetta, L. The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments. Benef. Microbes, 2018, 9(6), 899-916.
[http://dx.doi.org/10.3920/BM2017.0172] [PMID: 30232908]
[26]
Wei, D.; Heus, P.; van de Wetering, F.T.; van Tienhoven, G.; Verleye, L.; Scholten, R.J. Probiotics for the prevention or treatment of chemotherapy‐or radiotherapy‐related diarrhoea in people with cancer. Cochrane Database Syst. Rev., 2018, 8.
[http://dx.doi.org/10.1002/14651858.CD008831.pub3]
[27]
van Vliet, M.J.; Harmsen, H.J.; de Bont, E.S.; Tissing, W.J. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog., 2010, 6(5)e1000879
[http://dx.doi.org/10.1371/journal.ppat.1000879] [PMID: 20523891]
[28]
Caballero-Franco, C.; Keller, K.; De Simone, C.; Chadee, K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292(1), G315-G322.
[http://dx.doi.org/10.1152/ajpgi.00265.2006] [PMID: 16973917]
[29]
Vitetta, L.; Briskey, D.; Alford, H.; Hall, S.; Coulson, S. Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology, 2014, 22(3), 135-154.
[http://dx.doi.org/10.1007/s10787-014-0201-4] [PMID: 24633989]
[30]
Qin, H-L.; Shen, T-Y.; Gao, Z-G.; Fan, X-B.; Hang, X-M.; Jiang, Y-Q.; Zhang, H.Z. Effect of lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J. Gastroenterol., 2005, 11(17), 2591-2596.
[http://dx.doi.org/10.3748/wjg.v11.i17.2591] [PMID: 15849817]
[31]
Dimidi, E.; Christodoulides, S.; Scott, S.M.; Whelan, K. Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv. Nutr., 2017, 8(3), 484-494.
[http://dx.doi.org/10.3945/an.116.014407] [PMID: 28507013]
[32]
Reyna-Figueroa, J.; Barrón-Calvillo, E.; García-Parra, C.; Galindo-Delgado, P.; Contreras-Ochoa, C.; Lagunas-Martínez, A.; Campos-Romero, F.H.; Silva-Estrada, J.A.; Limón-Rojas, A.E. Probiotic supplementation decreases chemotherapy-induced gastrointestinal side effects in patients with acute leukemia. J. Pediatr. Hematol. Oncol., 2019, 41(6), 468-472.
[http://dx.doi.org/10.1097/MPH.0000000000001497] [PMID: 31033786]
[33]
Lau, C.S.M.; Ward, A.; Chamberlain, R.S. Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori : A meta-analysis. Infect. Drug Resist., 2016, 9, 275-289.
[http://dx.doi.org/10.2147/IDR.S117886] [PMID: 27994474]
[34]
Picó-Monllor, J.A.; Mingot-Ascencao, J.M. Search and selection of probiotics that improve mucositis symptoms in oncologic patients. A systematic review. Nutrients, 2019, 11(10), 2322.
[http://dx.doi.org/10.3390/nu11102322] [PMID: 31581434]
[35]
Shu, Z.; Li, P.; Yu, B.; Huang, S.; Chen, Y. The effectiveness of probiotics in prevention and treatment of cancer therapy-induced oral mucositis: A systematic review and meta-analysis. Oral Oncol., 2020, 102104559
[http://dx.doi.org/10.1016/j.oraloncology.2019.104559] [PMID: 31923856]
[36]
Miarons, M.; Roca, M.; Salvà, F. The role of pro-, pre- and symbiotics in cancer: A systematic review. J. Clin. Pharm. Ther., 2021, 46(1), 50-65.
[http://dx.doi.org/10.1111/jcpt.13292] [PMID: 33095928]

Rights & Permissions Print Cite
Article Metrics
19
1
© 2024 Bentham Science Publishers | Privacy Policy